Provider- and facility-level factors in relation to patients’ receipt of chemotherapy, time to chemotherapy initiation, and receipt of guideline regimens: Results from the optimal breast cancer chemotherapy dosing study.
Year: 2023
Type: conference-abstract
Source: JCO Oncology Practice
Authors: Elizabeth Kantor, Kelli O'Connell, Jenna Bhimani, Isaac J. Ergas, Narre Heon, Grace B Gallagher, Jennifer J. Griggs, Tatjana Kolevska, Yuriy Kotsurovskyy, Candyce Kroenke, Cecile Laurent, Raymond Liu, Sonia Persaud, Donna Rivera, Janise M. Roh, Sara Tabatabai, Emily Valice, Elisa Victoria Bandera, Erin Aiello Bowles, Lawrence H. Kushi
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W4388201479
